This round table brings together perspectives from across the bioprocessing and biomanufacturing value chain. The discussion will explore major technological breakthroughs, including single-use systems, process intensification, automation, continuous bioprocessing, advanced analytics, AI and digitalization, while examining their real-world impact on process development and manufacturing. Speakers from SEDA Manufacturing Development Services, Celltoki, Lonza, Alfa Laval and Agilent will address the challenges of translating innovative processes from development to GMP and commercial scale, including technology transfer, process robustness, data quality, analytical control and manufacturing efficiency. The roundtable will also consider how new equipment, smarter analytics and more sustainable processing technologies can improve productivity and flexibility. A key part of the conversation will focus on the evolving CMO/CDMO business model, including integrated development and manufacturing services, flexible capacity, strategic partnerships and risk-sharing approaches. By bringing together technology providers, process specialists and manufacturing organizations, the session aims to provide a balanced view of the opportunities and bottlenecks shaping the future of biomanufacturing.
SEDA Pharmaceutical Development Services Development-to-manufacturing integration, CMC, manufacturability, clinical supply and flexible outsourced development models
Alfa Laval. Analytical technologies, process understanding, characterization, quality and data-driven manufacturing
